Vanda Pharmaceuticals buy Truist Financial Co.
Start price
05.03.26
/
50%
€6.80
Target price
05.03.27
€15.49
Performance (%)
-30.82%
Price
18.08.26
€4.70
Summary
This prediction is currently active. Massive losses of -30.82% have been the result for the BUY prediction by Truist_Financial_Co_. This prediction currently runs until 05.03.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | 10.474% | 10.474% |
| iShares Core DAX® | -0,87 % | 5,32 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % |
| iShares S&P 500 | -0,65 % | 2,07 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (VNDA) is now covered by Truist Financial Corporation. They set a "buy" rating and a $18.00 price target on the stock.
Ratings data for VNDA provided by MarketBeat